Blood products company Haemonetics (NYSE:HAE). reported Q2 CY2025 results , but sales fell by 4.4% year on year to $321.4 million. Its non-GAAP profit of $1.10 per share was 8.3% above analysts’ ...

BOSTON, May 23, 2024 /PRNewswire/ -- Haemonetics Corporation (HAE) today announced the pricing of its offering of $600,000,000 aggregate principal amount of 2.50% Convertible Senior Notes due 2029 ...

BOSTON, April 4, 2024 /PRNewswire/ -- Haemonetics Corporation (HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, announced ...

BOSTON, Nov. 7, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its second quarter fiscal year 2025, which ended September 28, 2024, are available on its ...

BOSTON, March 5, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical products and solutions to drive better patient ...

Haemonetics (NYSE:HAE) has been analyzed by 11 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. Summarizing their recent assessments, the table ...

AlphaQuest LLC boosted its position in shares of Haemonetics Co. (NYSE:HAE – Free Report) by 36,520.0% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm ...

Providing a diverse range of perspectives from bullish to bearish, 11 analysts have published ratings on Haemonetics (NYSE:HAE) in the last three months. The following table provides a quick overview ...

BOSTON, Jan. 9, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient outcomes, today ...

BOSTON (AP) — BOSTON (AP) — Haemonetics Corp. (HAE) on Thursday reported fiscal third-quarter earnings of $44.7 million. The Boston-based company said it had net income of 95 cents per share. Earnings ...